Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q1

7459.TEDINET S100RN8E
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥886.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥3.36T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥838.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥12.4bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥13.5bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥16.7bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥65.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥17.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥20.0bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥17.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥11.2bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥38.8bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥8.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥13.9bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥10.8bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥1.78Tat 2023-06-30Cons.Assets
Total assets¥1.71Tat 2023-03-31Cons.Assets
Total assets¥1.72Tat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥1.07Tat 2023-06-30Cons.Liabilities
Total liabilities¥1.02Tat 2023-03-31Cons.Liabilities
Net assets / equity¥710.1bnat 2023-06-30Cons.Net assets
Net assets / equity¥688.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥659.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥200.2bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥195.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥52.322023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.822022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥39.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥179.122022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.942022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio32.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio32.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥903m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥903m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥49m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥28.9bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥28.9bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥0
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥831m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥293.5bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥293.4bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥74m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥7.0bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥565.2bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥564.4bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥828m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥887.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥886.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥903m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥12.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30¥98m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥692m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥94m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.5bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥544.4bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥543.6bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥817m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥839.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥838.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥913m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥13.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 380
ItemContextValueUnit
Provision for bonusesCurrentQuarterInstant5149000000JPY
Provision for loss on anti monopoly act clPrior1YearInstant5704000000JPY
Provision for loss on anti monopoly act clCurrentQuarterInstant5704000000JPY
Other clPrior1YearInstant54875000000JPY
Other clCurrentQuarterInstant51838000000JPY
Current liabilitiesPrior1YearInstant971519000000JPY
Current liabilitiesCurrentQuarterInstant1013989000000JPY
Net defined benefit liabilityPrior1YearInstant16909000000JPY
Net defined benefit liabilityCurrentQuarterInstant16948000000JPY
Other nclPrior1YearInstant33175000000JPY
Other nclCurrentQuarterInstant38446000000JPY
Noncurrent liabilitiesPrior1YearInstant50084000000JPY
Noncurrent liabilitiesCurrentQuarterInstant55395000000JPY
LiabilitiesPrior1YearInstant1021603000000JPY
LiabilitiesCurrentQuarterInstant1069384000000JPY
Capital stockPrior1YearInstant22398000000JPY
Capital stockCurrentQuarterInstant22398000000JPY
Capital surplusPrior1YearInstant101597000000JPY
Capital surplusCurrentQuarterInstant102147000000JPY
Retained earningsPrior1YearInstant414723000000JPY
Retained earningsCurrentQuarterInstant421082000000JPY
Treasury stockPrior1YearInstant-26288000000JPY
Treasury stockCurrentQuarterInstant-21237000000JPY
Shareholders equityPrior1YearInstant512430000000JPY
Shareholders equityCurrentQuarterInstant524391000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant61439000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant68926000000JPY
Deferred gains or losses on hedgesPrior1YearInstant5000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant253000000JPY
Revaluation reserve for landPrior1YearInstant-13700000000JPY
Revaluation reserve for landCurrentQuarterInstant-13700000000JPY
Foreign currency translation adjustmentPrior1YearInstant1547000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant1712000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-364000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-306000000JPY
Valuation and translation adjustmentsPrior1YearInstant48927000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant56885000000JPY
Non controlling interestsPrior1YearInstant126697000000JPY
Non controlling interestsCurrentQuarterInstant128811000000JPY
Net assetsPrior1YearInstant688055000000JPY
Net assetsCurrentQuarterInstant710087000000JPY
Liabilities and net assetsPrior1YearInstant1709658000000JPY
Liabilities and net assetsCurrentQuarterInstant1779472000000JPY
Net salesPrior1YTDDuration838328000000JPY
Net salesCurrentYTDDuration886737000000JPY
Cost of salesPrior1YTDDuration782302000000JPY
Cost of salesCurrentYTDDuration827400000000JPY
Gross profitPrior1YTDDuration56026000000JPY
Gross profitCurrentYTDDuration59336000000JPY
Salaries and allowances sgaPrior1YTDDuration16137000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass